Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic
Blood Cancer Journal, Published online: 15 March 2023; doi:10.1038/s41408-023-00795-wDelayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 15, 2023 Category: Hematology Authors: Jonathan Carmichael Frances Seymour Graham McIlroy Sarrah Tayabali Rosie Amerikanou Sylvia Feyler Rakesh Popat Guy Pratt Christopher Parrish A. John Ashcroft Graham H. Jackson Gordon Cook Source Type: research
MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas
Blood Cancer Journal, Published online: 15 March 2023; doi:10.1038/s41408-023-00809-7MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 15, 2023 Category: Hematology Authors: Marthe Minderman Hildo C. Lantermans Leonie J. Gr üneberg Saskia A. G. M. Cillessen Richard J. Bende Carel J. M. van Noesel Marie Jos é Kersten Steven T. Pals Marcel Spaargaren Source Type: research
Current CML guidelines overemphasize second generation TKIs: revisiting the paradigm
Blood Cancer Journal, Published online: 15 March 2023; doi:10.1038/s41408-023-00811-zCurrent CML guidelines overemphasize second generation TKIs: revisiting the paradigm (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 15, 2023 Category: Hematology Authors: Anushka Walia Vinay Prasad Source Type: research
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Blood Cancer Journal, Published online: 13 March 2023; doi:10.1038/s41408-023-00812-yAbnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 13, 2023 Category: Hematology Authors: Mostafa Abdallah Kristen McCullough Rimal Ilyas Kebede H. Begna Aref Al-Kali Mark R. Litzow William J. Hogan Abhishek Mangaonkar Hassan Alkhateeb Mithun V. Shah Michelle A. Elliott James M. Foran Talha Badar Jeanne M. Palmer Cecilia Arana Yi Lisa Sproat A Source Type: research
Infectious complications of bispecific antibody therapy in patients with multiple myeloma
Blood Cancer Journal, Published online: 10 March 2023; doi:10.1038/s41408-023-00808-8Infectious complications of bispecific antibody therapy in patients with multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 10, 2023 Category: Hematology Authors: Beatrice Z. Sim Anthony Longhitano Jeremy Er Simon J. Harrison Monica A. Slavin Benjamin W. Teh Source Type: research
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS
Blood Cancer Journal, Published online: 07 March 2023; doi:10.1038/s41408-023-00805-xDaratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 7, 2023 Category: Hematology Authors: Philippe Moreau Ajai Chari Albert Oriol Joaquin Martinez-Lopez Mathias Haenel Cyrille Touzeau Sikander Ailawadhi Britta Besemer Javier de la Rubia Comos Cristina Encinas Maria-Victoria Mateos Hans Salwender Paula Rodriguez-Otero Cyrille Hulin Lionel Karli Source Type: research
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients
Blood Cancer Journal, Published online: 06 March 2023; doi:10.1038/s41408-023-00794-xIntegrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 6, 2023 Category: Hematology Authors: Rodrigo Fonseca Mariano Arribas Julia E. Wiedmeier-Nutor Yael N. Kusne Miguel Gonz ález Vélez Heidi E. Kosiorek Richard (Duke) J. Butterfield Ilan R. Kirsch Joseph R. Mikhael A. Keith Stewart Craig Reeder Jeremy Larsen P. Leif Bergsagel Rafael Fonseca Source Type: research
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy
Blood Cancer Journal, Published online: 27 February 2023; doi:10.1038/s41408-023-00802-0Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 27, 2023 Category: Hematology Authors: Maria Moscvin Christine Ivy Liacos Tianzeng Chen Foteini Theodorakakou Despina Fotiou Shahrier Hossain Sean Rowell Houry Leblebjian Eileen Regan Peter Czarnecki Filippo Bagnoli Niccolo ’ Bolli Paul Richardson Helmut G. Rennke Meletios A. Dimopoulos Efst Source Type: research
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
Blood Cancer Journal, Published online: 24 February 2023; doi:10.1038/s41408-023-00803-zDynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 24, 2023 Category: Hematology Authors: Somayya Noori Charissa Wijnands Pieter Langerhorst Vincent Bonifay Christoph Stingl Cyrille Touzeau Jill Corre Aurore Perrot Philippe Moreau H élène Caillon Theo M. Luider Thomas Dejoie Joannes F. M. Jacobs Martijn M. van Duijn Source Type: research
Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
Blood Cancer Journal, Published online: 20 February 2023; doi:10.1038/s41408-023-00801-1Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 20, 2023 Category: Hematology Authors: Kathryn T. Maples Kevin H. Hall Nisha S. Joseph Craig C. Hofmeister Vikas Gupta Madhav V. Dhodapkar Jonathan L. Kaufman Ajay K. Nooka Sagar Lonial Source Type: research
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations
Blood Cancer Journal, Published online: 17 February 2023; doi:10.1038/s41408-023-00799-6Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 17, 2023 Category: Hematology Authors: Yuxuan Che Yang Liu Yixin Yao Holly A. Hill Yijing Li Qingsong Cai Fangfang Yan Preetesh Jain Wei Wang Lixin Rui Michael Wang Source Type: research
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
Blood Cancer Journal, Published online: 17 February 2023; doi:10.1038/s41408-023-00798-7Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 17, 2023 Category: Hematology Authors: Alexander J. Ryu Shaji Kumar Angela Dispenzieri Robert A. Kyle S. Vincent Rajkumar Thomas C. Kingsley Source Type: research
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases
Blood Cancer Journal, Published online: 17 February 2023; doi:10.1038/s41408-023-00800-2CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 17, 2023 Category: Hematology Authors: Rimal Ilyas Kristen McCullough Talha Badar Mrinal M. Patnaik Hassan Alkhateeb Abhishek Mangaonkar Animesh Pardanani Ayalew Tefferi Naseema Gangat Source Type: research
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
Blood Cancer Journal, Published online: 13 February 2023; doi:10.1038/s41408-023-00796-9Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 13, 2023 Category: Hematology Authors: Sridurga Mithraprabhu John Reynolds Rose Turner Hang Quach Noemi Horvath Ian Kerridge Anna Kalff Krystal Bergin Jay Hocking Flora Yuen Tiffany Khong Brian M. Durie Andrew Spencer Source Type: research
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
Blood Cancer Journal, Published online: 07 February 2023; doi:10.1038/s41408-023-00793-yCorrection: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 7, 2023 Category: Hematology Authors: Keiji Kurata Anna James-Bott Mark A. Tye Leona Yamamoto Mehmet K. Samur Yu-Tzu Tai James Dunford Catrine Johansson Filiz Senbabaoglu Martin Philpott Charlotte Palmer Karthik Ramasamy Sarah Gooding Mihaela Smilova Giorgia Gaeta Manman Guo John C. Christian Source Type: research
